Treatment modalities in COVID 19

dc.authorid	0000-0001-5687-8531
dc.authorid	0000-0001-7612-2707
dc.contributor.author	Çiftçiler, Rafiye
dc.contributor.author	Çiftçiler, Ali
dc.date.accessioned	2021-08-16T06:37:53Z
dc.date.available	2021-08-16T06:37:53Z
dc.date.issued	2021
dc.department	Tıp Fakültesi
dc.description.abstract	The new SARS-CoV-2 virus continues to spread rapidly around the world. As the world struggles to minimize the transmission of this devastating disease, various strategies and interventions are actively being implemented to improve treatment. Pharmaceutical companies and academic researchers are working relentlessly to search for experimental, fit-for-purpose, or FDA-approved drugs for SARS-CoV-2 prophylaxis and treatment. This review provides an overview of the current therapeutic modalities being evaluated against the SARS-CoV-2 virus.
dc.identifier.endpage	21	en_US
dc.identifier.issn	2757-6655
dc.identifier.issue	1	en_US
dc.identifier.startpage	20	en_US
dc.identifier.uri	https://hdl.handle.net/20.500.12451/8538
dc.identifier.volume	2	en_US
dc.language.iso	en
dc.publisher	Aksaray Üniversitesi
dc.relation.ispartof	Aksaray Üniversitesi Tıp Bilimleri Dergisi / Aksaray University Journal of Medical Sciences
dc.relation.publicationcategory	Konferans Öğesi - Ulusal - Kurum Öğretim Elemanı
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	COVID19
dc.subject	SARS-CoV-2
dc.subject	Treatment
dc.subject	Vaccine
dc.title	Treatment modalities in COVID 19
dc.title.alternative	COVID19’ da tedavi yöntemleri
dc.type	Presentation